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IMMUNOLOGICAL UNRESPONSIVENESS IN ALLERGIC CONTACT
DERMATITIS TO DINITROCHLOROBENZENE IN GUINEA PIGS5
J. R. FREY, M.D.,t A. L. DE WECK, M.D.t AND H. GELEICKt
In previous experiments (1, 2) dealing with
allergic contact dermatitis of the guinea pig to
2:4-dinitro-1-chlorobcnzene (DNCB), a partial
or total, but short-lived inhibition of the hyper-
sensitivity state could he obtained by injecting
intravenously DNCB or the immunologically
related 2: 4-dinitrobcnzcnc sulfonic acid sodium
salt (DNBSO3) in already sensitized animals.
In the present experiments, a permanent state
of unresponsiveness was obtained by giving
DNBSO3 intravenously before sensitization. So
pretreated animals did not become sensitized and
remained unresponsive after repeated epicutane-
ous applications of DNCB. These results confirm
the early work of Sulzbcrgcr (23), as well as that
that of Chase (3, 4) who showed that the admin-
istration of the allergen prior to the sensitizing ap-
plication may induce a total or partial immuno-
logical unresponsiveness in adult animals, and
not only in newborn animals usually considered
for immunological tolerance (5).
MATERIALS AND METHODS
2:4-dinitrobenzenesulfonic acid sodium salt
(DNBSO3) was obtained from Eastman Kodak,
Rochester, N. Y.; 2: 4-dinitro-1 -chlorobenzenc
(DNCB), reagent grade, from Merck, Darmstadt;
and a-2-chloro-9 (3-dimethylaminopropylidene)
thioxanthene hydrochloride, Chlorprothixene hy-
drochloride (CPT) from Hoffmann-La Roche, Inc.,
Basic. White semi-inbred guinea pigs of both sexes
weighing 400—500 g were used throughout.
The general disposition of our experiments con-
sisted in a) pretreating the animals with DNBSO3,
b) sensitizing them with DNCB and/or CPT and
c) testing them later with these compounds in
order to determine the effect of the pretreatment
or their capacity to react.
Pre-treatment
DNBSO3 was administered as one single i.v.
injection in a vein of the hind leg in doses of 750,
500, 250 and 125 mg/kg to different groups of 6—S
guinea pigs 28, 14, 7, 3, 2 and 1 day before and 1
day after the sensitizing contact with DNCB.
DNBSO3 was dissolved in bi-distilled water or
saline and, according to the dose, concentrations
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of 25, 12, 5 and 6.25% were used. The volumes in-
jected varied from 0.8 to 1.5 ml.
Sensitization Technic
a) DNCB: 0.002 ml of a 50% solution of DNCB in
acetone was applied with a micro-pipette on the
epilated skin of the nuchal region on an area of
2—5 mm diameter. This technic published else-
where (6) induces sensitization in 100% of the ani-
mals used.
b) CPT: Intradermal injection of 0.1 ml of a
20% aqueous solution was given on three alternate
days.
e) In order to determine the specificity of the
phenomena investigated, one group of 16 guinea
pigs was pretreated with DNBSO3, then sensi-
tized simultaneously to DNCB and CPT and
tested weekly with both substances.
Skin Testing
a) DNGB: 14 days after sensitization and then
at weekly intervals, the animals were tested with 3
different concentrations of DNCB in acetone by
applying 0.025 ml of a 0.9, 0.5 and 0.3 per mille
solution on a circular area of 2 cm2 of the skin of
the flank.
b) CPT: Epicutaneous application of 0.025 ml of
aqueous solutions of 10, 3 and 1 per cent.
The tests were read 24 hours later and evaluated
as follows: 0.5: some red spots in the test area; 1:
slight reddening; 2: marked reddening and
swelling; 3: marked reddening and marked swell-
ing.
The sum of the readings obtained with three
different test concentrations gives some numerical
estimate of the hypersensitivity level of the animal
tested and of the average sensitivity of a group as
published elsewhere (6).
Controls
a) 32 guinea pigs not pretreated but similarly
sensitized and tested with DNCB (positive con-
trols).
b) 18 animals neither pretreated nor sensitized
but tested with DNCB at the same intervals as
the experimental groups (negative controls).
EXPERIMENTS AND RESULTS (TARLR 1)
Our experiments were performed in order to
determine: the influence of intravenously admin-
istered DNBSO3 (pretreatment) on the capacity
of immunologic response to subsequent epicutanc-
ous sensitization with DNCB, the influence of
the dose and the time of injection of DNBSO3 on
the occurrence of unresponsiveness, the duration
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TABLE I
DNBS03 i.v.
Unresponsiveness to DNCB contact in guinea pigs pretreated by one
intravenous injection of DNBSO3
Results° of Skin Tests With DNCB According to Weeks
After Sensitizing Application of DNCBt
2 3 16 38Experiment
Days before
primary mg/kg
contact
1 28 500
2 14 750
3 14 500
4 14 250
5 14 125
6 7 750
7 7 500
8 3 750
9 3 500
10 2 500
11 1 500
12 1 day after 500
primary
contact
— Unre-
sponsive
+ = Re-
sponsive
+
+
+
+
+
+
+
+
+
+
+
+
Num-
ber of
animals
4
4
4
2
10
5
2
5
0
8
2
4
5
10
2
5
0
8
0
7
0
8
0
8
Inten-
sity
0.5
0.5
0.7
1.1
1.0
0.8
0.7
0.5
0.8
1.6
0.9
1.6
Num-
ber of
animals
4
4
3
3
7
6
2
5
0
6
2
4
S
10
2
5
0
7
0
7
0
8
0
8
Inten-
sity
0.8
1.0
1.1
1.4
1.7
0.6
1.0
0.6
1.1
1.5
1.2
1.7
Num-
ber of
animals
2
1
2
3
0
5
0
6
1
4
0
3
0
3
0
6
0
7
Inten-
sity
1.5
1.1
1.1
1.3
1.1
1.0
0.8
1.3
1.5
Num-
ber of
animals
2
1
2
3
0
4
0
5
1
4
0
2
0
3
0
6
0
6
Inten-
sity
0.5
0.5
0.5
0.6
1.0
0.8
0.5
0.7
0.8
13 Positive controlsil —
+
0
32
2.7 0
31
3.4 0
18
2.4 0
12
2.6
14 Negative controlsf —
+
18
0
0 9
9
0.5 0
18
2.5
* Epicutaneous tests with DNCB were carried out weekly for 24 weeks with 0.9, 0.5 and 0.3% solu-
tions of DNCB in acetone. Only the figures for weeks 2, 3, 14, 16, 20 and 24 are mentioned.
f The animals were sensitized by applying 0.002 ml of a 50% solution of DNCB in acetone epicutane-
ously.
* Second sensitizing application 14 weeks after first.
§ Intensity expressed as mean of the three test reactions.
No pretreatment but sensitizing application and skin testing.
¶ No pretreatment, no sensitizing application, only skin testing.
For further details see chapter II.
of the diminished or abolished responsiveness and
the effect of repeated epicutaneous application
and testing on unresponsiveness.
Design of the experiments and the results are
summarized in Table 1 and may be analyzed as
follows: e) Duration of these effects.
a) Number of animals completely unrespon-
sive compared to total number of animals
pretreated and sensitized.
b) Sensitivity level of the partially responsive
animals.
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It may be concluded that pretreatment with
DNBSO3 induces in a high proportion of the ani-
mals a complete unresponsiveness to a subsequent
sensitizing contact with DNCB (experiments
1, 2, 3, 4, 7 and 8). This effect persists for 38
weeks despite the weekly testing and a second
sensitizing application performed in the surviv-
ing animals (experiments 2, 3 and 7).
The unresponsiveness seems to be proportional
to the dose of DNBSO3 administered (experi-
ments 2 and 3 versus 4 and 5) as no effect is
obtained when less than 250 mg/kg are given. The
proportion of unresponsive animals could not be
enlarged by administering higher doses of
DNBSO3 when injected 14 or 7 days before
sensitization (experiments 3 versus 2 and 7 versus
6). However, when 750 mg/kg DNBSO3 was given
3 days before the sensitizing contact (experiment
9 versus 8), high doses were definitely more
effective.
The unresponsiveness is further related to the
time of injection of the hapten. No effect is
observed with 500 mg/kg when less than 7 days
elapse between pretreatment and sensitization
(experiments 3 versus 7, 9—12). However, when
higher doses of DNBSO3 are given as late as 3
days before the sensitizing application (experi-
ment 8), unresponsiveness is still obtained.
Complete unresponsiveness in a similar pro-
portion of animals is obtained when pretreatment
is performed 28, as well as 14, days before sen-
sitization (experiments 3 and 2 versus 1).
In those pretreated animals which responded
to sensitization, the acquired degree of sensitiv-
ity was distinctly lower than that of the positive
controls. In fact, their sensitivity level oscillates
around 0.5 to 1.7, whereas the controls showed
values of 2.4 to 3.4. This partial responsiveness
occurred without apparent correlation to the dose
and the time of injection of DNBSO3; it persisted
for 38 weeks; and could not be raised either by
repeated testing or by a second sensitizing ap-
plication.
In the non-pretreated but similarly sensi-
tized group (positive controls, experiment 13),
all the animals did respond, their sensitivity
level reaching the usual high value which re-
mained constant until the end of the experiment.
In the non-pretreated and not sensitized group
(negative controls, experiment 14), the sensitizing
effect of repeated testing with "primarily non-
irritating" concentrations of DNCB is shown. All
these animals became positive at the time of the
fourth test and their sensitivity level was com-
parable to the level of positive controls at the
time of the fifth test.
Specificity of Unresponsiveness (Table 2)
In order to determine whether unresponsive-
ness due to pretreatment is a specific phenome-
TABLE 2
Specificity of the unresponsiveness in guinea pigs pretreated by one intravenous injection of DNBSOS and
double-sensitized 14 days later by epicutaneous application of DNCB and/or
intradermol injections of ('PT
Eapeei-
ments
Num-
ber of
Am-
mals
Pretreatment Sensitization Skin-testingwith
Skin Tests at weeks
2
Number of
animals
Unre- Re-
spons. spons.
Inten-
sity
5
—
Number of
animals
Inten-
sityTore- Re-
spons. spons.
1
2
3
4
5
16
8
7
8
8
500 mg/kg DNBSO5
i.v. 14 days before
sensitization
—
—
—
DNCB e.c.
and CPT i.d.
DNCB e.e.
and ('PT i.d.
DNCBe.c.
CPTi.d.
—
DNCB
CPT
DNCB
('PT
DNCB
('PT
DNCB
('PT
10
0
0
0
0
0
88
6
16
8
8
7
8
0
0
0.7
1.87
2.63
2.19
2.36
2.07
0
0
6
0
0
0
0
0
0
1
7 1.2
13 2.27
7 3.21
7 2.63
6 3.0
8 2.6272.260.8
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non, one group of 16 animals (experiment 1)
where pretreated with DNBSO3 and 14 days later
sensitized concomitantly to two immunologically
unrelated compounds (DNCB and CPT). The
following necessary positive and negative controls
were done:
no pretreatment but double sensitizing and
testing (experiment 2)
no pretreatment but sensitizing and testing
either with DNCB or CPT (experiments 3—4)
no pretreatment, no sensitization, but testing
with both substances (experiment 5).
Results are summarized on Table 2. Complete
unresponsiveness to DNCB was obtained in a
high proportion of the double sensitized animals,
those responding acquired only a low level of
sensitivity. The concomitant sensitization to
CPT was not influenced by the pretreatment
and the same sensitivity level was acquired as
in the controls. All non-pretreated and non-
sensitized animals became positive after per-
forming 4 tests, i.e. after 5 weeks.
SEROLOGICAL STUDIES
Material and Methods
Precipitating anti-DNP antibody was investi-
gated by ring test using various DNP-protein con-jugates as antigens. Among these, DNP-bovine
gamma globulin (DNP-B7G), DNP-human serum
albumin (DNP-HSA) and DNP-guinea pig serum(DNP-GPS) were prepared by the method of
Eisen (7), dialyzed extensively and passed through
IRA-400 columns (8). The extent of substitution
of protein carriers by DNP haptenie groups was
determined spectrophotometrically (8). When
feasible, quantitative preeipitin analysis was
carried out (9).
ilemagglutination was performed by using
tanned sheep red blood cells incubated with DNP-
ByG or DNP-HSA at a concentration of 1—3 mg
protein/ml (10). The sensitivity of this assay, as
determined with guinea pig antisera of known
anti-DNP precipitating antibody content, was
found not to exceed 5 g Ab protein/mi.
Passive cutaneous anaphylaxis was performed
according to Ovary (11), using S mg DNP-B7G or
DNP-HSA as antigen. A latency time of 6 hours
between the intradermal injection of the sera and
TABLE 3
Circulating anti -DNP antibodies and immediate-type hypersensitivity in guinea pigs
after injection of DNP-ByG, DNCB, DNBSO5 and/or epicutaneous
application of DNCB
Results: positive animals/animals tested
Immunization procedure
Time
of test:
day
Precipitin
analysis
Hemagglu-
tination
Passive
cutaneous
anaphylaxis
Anaphylaxis
Death Symptoms
12/12
Contact re-
action to
DNCB
2±/12DNP25-ByG in Freund's
adjuvant (62-235 mMM
DNP/guinea pig) intra-
dermal
DNCB in Freund's adju-
vant (235 mpM/guinea
pig) intradermal
DNCB apieutaneous (5
MM/guinea pig)
DNBSO5 intravenous (2000
pM/guinea pig)
DNBSO5 intravenous (2000
pM/guinea pig) on day
0, 5MM DNCB epicutane-
ous on day 14
14
14
14
14
28
28
16++/16*
0/4
0/16
0/10
0/6
0/13
16++/16t
4+/4t
0/16
0/10
0/6
0/13
16++/161
0/8
0/10
0/6
0/13
8+ +/8
13+/16 16++/16
8/8
0/16
0/8
n.d.
0/2
8±/8 ¶1
n.d.
0/2
0/14
0/8
5±/l5
* Quantitative analysis on pool: 2.77 mg anti-DNP antibody protein/mi.
f Titers with DNP9-HSA incubated, tanned sheep red blood cells: 1/2560—1/10240.
t Titers with DNP5-HSA incubated, tanned sheep red blood cells: 1/2560—1/10240.
§ With DNP5-IISA (5mg) and 1% Evans Blue, positive until 0.3—0.5 pg Ab protein/0.1 ml.
II Estimated from dilution and reaction sizes: 20—40 pg Ab/ml.¶ Questionable symptoms of anaphylactic shock.
nd. Not done.
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the intravenous injection of antigen was found as
satisfactory as the latency time of 17 hours, which
has been sometimes recommended (12, 13). The
sensitivity of this assay was found to be 0.3—0.5
pg Ab protein/0.1 ml and is in agreement with data
published (13, 14).
Active anaphylaxis was induced by intravenous
injection of DNP-GyG or DNP-GPS conjugate
at doses of 0.8—8 pM DNP groups.
Serological Results (Table 8)
The following groups of differently sensitized
animals were investigated serologically:
1) Animals sensitized by four intradermal
injections of DNCB (0.235 gM) in Freund's
adjuvant in each foot-pad did exhibit a high level
of contact hypersensitivity and an intravenons
injection of IDNP-protein conjugates elicited
regularly a severe or lethal anaphylactic shock.
Circulating anti-DNP antibodies were demon-
strated by passive cutaneous anaphylaxis (PCA)
and hemagglutination (Table 3).
2) Animals sensitized by one single epicutaneous
application of 0.002 ml of 50% TJNCB in acetone
showed also a high level of contact hypersensitiv-
ity and an intravenous injection of DNP-protein
conjugates elicited a characteristic but not lethal
anaphylactic shock (Table 3). The sera of these
animals were investigated 14 days after sensitiza-
tion for anti-DNP antibodies by PCA and hem-
agglutination. No detectable anti-DNP anti-
bodies were found (Table 3).
3) Finally, animals pretreated intravenously
with DNBSO3 did not exhibit contact hyper-
sensitivity and, when injected with DNP-protein
conjugates 15 days after pretreatment, showed
only questionable symptoms of anaphylactic
shock. When sera of these animals were investi-
gated for anti-DNP antibodies 4 and 28 days
after the intravenous injection of DNBSO3, as
well as before and after the sensitizing epicutane-
ons application of DNCB, in no instance were
anti-DNP antibodies detectable (Table 3).
It maybe concluded from these serologic investi-
gations that no anti-DNP antibodies are detectable
by the technic currently used in animals sensitized
epicutaneously with DNCB (quoted under 2) and
in animals receiving DNBSO3 intravenously alone
and subsequently DNCB by epicutaneous appli-
cation (quoted under 3). As these animals show
weak or questionable anaphylactic reactivity
they must have circulating anti-DNP antibodies
at levels lower than detectable by the technics
used (0.9 Ab N yg/ml).
DIscussIon
If one compares our results obtained with
intravenous injection of DNBSO3 with those
reported previously by Chase (3), with the
feeding method, one will see that they are very
similar.
The unresponsiveness obtained in our animals
is specific, durable, and shows very little tendency
to reversal, even after repeated contact with the
allergen. The induction of unresponsiveness de-
pends clearly upon the dose and the time interval
between pretreatment and sensitization. 7 days
have to elapse after the pretreatment with 500
mg/kg or 3 days after giving 750 mg/kg in order
to obtain unresponsiveness to subsequent sen-
sitizing applications. From Chase's experience,
it appears that the animals must rest several
weeks between the pretreatment (feedings) and
the sensitizing procedure. The intravenous pro-
cedure has over the feeding procedure the advan-
tage of simplicity, to require only one injection,
and to make possible evaluation of dose and time
relationships. Regularity and intensity of un-
responsiveness seem at least as good as with the
feeding method.
When only partial unresponsiveness is a-
ehieved, the pretreatment with DNBSO3 impairs
to a large extent the reactivity towards DNCB as
these animals reach only a low hypersensitivity
level.
From Battisto's recently published results
(26), it would seem that the injection of the
allergen in the mesenteric veins would be especi-
ally effective and would require only minute
amounts of allergen. A comparative study might
be of interest; nevertheless the mesenterie intra-
venous route is not an absolute requirement.
No anti-DNP antibodies were found by the
usual teehnics in our animals pretreated with
DNBSO3 with or without subsequent sensitizing
contact with DNCB in spite of the fact that a
questionable anaphylactic shock could be in-
duced.
The mechanisms underlying the unresponsive
state obtained in our experiments are unknown
and can only be theoretically discussed at the
present time.
1) The fact that in this system a minimal in-
terval of 3—7 days is required between the pre-
treatment and the first sensitizing contact could
suggest that we are dealing with an "antibody-
induced unresponsiveness" (22). It could be
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assumed that the intravenous injection of
DNBSO3 will induce formation of anti-DNP
antibodies. The DNP protein conjugates formed
upon the subsequent sensitizing epicutaneous
application of DNCB would then be readily
picked up by already present anti-DNP anti-
bodies and would be destroyed (phagocytosis
of antigen-antibody complexes) before having
reached the elements responsible for induction of
contact-type hypersensitivity. The absence of
detectable anti-DNP antibodies and the only
questionable anaphylactic reactivity in animals
having received one i. v. injection of DNBSO3
make this hypothesis unlikely. The following
experiments also speak against this hypothesis:
Animals injected once intravenously with
DNP-GPS did not show anaphylactic reactivity
but became, after sensitizing contact with DNCB,
only partially responsive, reaching hypersensitiv-
ity levels of 1.5 as compared to controls 2.8
(unpublished data).
Furthermore, animals injected intracutane-
ously with DNP-B-YG or DNP-GPS in Freund's
adjuvant, presenting high titers of anti-DNP
antibodies and lethal anaphylactic reactivity
but practically no contact reactivity to DNCB,
became sensitized as normal controls by sub-
sequent epicutaneous application of DNCB
(unpublished data).
Sera of Chase's "fed" animals, injected into
animals undergoing active sensitization, did not
alter the development of dermal sensitization
(4). It is then 'unlikely that we are dealing here with
an "antibody-induced unresponsiveness".
It cannot be decided if we are concerned with
an "immunological paralysis" or "masking"
related to the persistence of the antigen, or with
an "immunological tolerance" due to a perma-
nent impairment of the capacity to become
sensitized.
2) If one considers immunological paralysis
(15, 16, 17, 18, 23), one could conceive a con-
tinuous neutralization of newly synthetized anti-
bodies and/or specific cells by antigen deposits
remaining in the tissues. However, direct evi-
dence with radioactive labelled allergen, as well
as the failure of tissues of picryl "fed" animals
to adsorb anti-picryl antibodies, does not lend
support to the "masking" concept (4, 22).
Furthermore, one would expect, unless the
allergen has no turnover and becomes forever
fixed in the tissues, that the neutralization ability
would change with time, therefore that both
unresponsive and partially responsive animals
would become increasingly responsive with time,
which is apparently not the case.
3) Finally, the fact that we can obtain totally
unresponsive animals which do not respond even
to strong and repeated antigenic stimuli suggests
that some profound impairment of the sensitizing
ability, as conceived for immunologic tolerance,
(19, 21, 24, 25) may have been achieved. How-
ever, it might be argued that the repeated anti-
genie stimuli are by themselves responsible for
the extension of the tolerant state (20). Whether
the effect is due to the formation by the allergen
of intracellular "immunologic chimara" blocking
or preventing antibody formation and/or to the
destruction by an overflow of allergen of specifi-
cally competent cells according to the clonal
hypothesis, cannot be decided (20).
SUMMARY
In adult guinea pigs, an intravenous injection
of high doses of 2 :4-dinitrobenzene sulfonic acid
(DNBSO3) prior to a sensitizing epicutaneous
application of 2: 4-dinitrochlorobenzene (DNCB)
induces a complete or partial but specific state of
unresponsiveness to a subsequent contact with
DNCB for as long as 38 weeks.
The induction of the unresponsive state seems
to be correlated to the dose administered and the
time elapsed between the injections of DNBSO3
and the sensitizing application of DNCB.
The incapacity to develop contact type sen-
sitization seems to go along with an impairment
of the ability to form circulating anti-DNP anti-
bodies (immunologic tolerance).
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